Prime Therapeutics names Ann Tobin as Chief Compliance Officer

        Prime Therapeutics names Ann Tobin as Chief Compliance Officer

PR Newswire

ST. PAUL, Minn., Jan. 28, 2013

ST. PAUL, Minn., Jan. 28, 2013 /PRNewswire/ --Prime Therapeutics (Prime), a
leading pharmacy benefit manager (PBM), announced today that it has hired Ann
Tobin as Chief Compliance Officer.

Tobin will oversee the company's corporate compliance function. She will work
with the company's leadership and employees to help assure that its PBM
products and services comply with state and federal regulations.

"Ann brings a wealth of regulatory experience and knowledge in the health care
industry," said Eric Elliott, president and CEO at Prime Therapeutics. "We are
confident Ann will create a best-in-class compliance program that advances
Prime's purpose of helping people get the medicine they need to feel better
and live well."

Tobin has more than 20 years of strong regulatory compliance leadership in the
health care industry, with a particularly strong focus on health plans and
pharmacy benefit management. Previous to Prime, she held various legal
leadership roles at UnitedHealth Group, Diversified Pharmaceutical Services
and Medtronic.

Tobin holds academic degrees from Duke University and Oberlin College. She
earned her law degree from Northwestern University School of Law.

About Prime Therapeutics
At Prime Therapeutics, people are at the center of all we do and every
decision we make. As a leader in pharmacy benefit management, Prime is
dedicated to making it easier for our members to obtain more affordable
medicines. We leverage our unique connections to deliver programs that lead
to the best health outcomes for our members.

Prime's integrated pharmacy benefit management services include claims
processing, benefit plan design, network management, clinical program
consultation, rebate management, formulary administration, mail service
pharmacy and specialty pharmacy.

Headquartered in St. Paul, Minn., Prime Therapeutics serves nearly 20 million
people and is collectively owned by 13 Blue Cross and Blue Shield Plans,
subsidiaries or affiliates of those plans. Prime has been recognized as one
of the fastest-growing private companies in the nation by Inc. 5000 and as a
most engaged workplace by Achievers.

For more information, visit www.primetherapeutics.comor follow @Prime_PBM on

SOURCE Prime Therapeutics

Contact: Sheila Thelemann, Prime Therapeutics, Director, Corporate
Communication, +1-612-777-5508,
Press spacebar to pause and continue. Press esc to stop.